How many subsidiaries does Edwards Lifesciences Corp file with the SEC?

6, listed in its most recent exhibit 21. They are incorporated across 4 jurisdictions (Delaware, France, Japan, Germany). That exhibit is filed with the company's annual report and is the company's own list, not an estimate.

Is Edwards Lifesciences Corp financially healthy?

Edwards Lifesciences Corp scores 6 out of 9 on the Piotroski F-score. Its Altman Z-score puts it in the safe zone. Every test and the numbers behind it are shown above, so the arithmetic is checkable rather than something you have to take on trust.

Who are the largest institutional holders of Edwards Lifesciences Corp?

Among the managers tracked here, the biggest positions as of the 2026-Q2 13F filings are BlackRock, Inc. (adding), STATE STREET CORP (adding), JPMORGAN CHASE & CO (adding). Direction is the change in share count against that manager's own previous filing; managers with no prior filing are left out rather than counted as new buyers.

Edwards Lifesciences Corp (EW)

NYSE · Common Stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies

One email a week from me: what it filed, which 13F holders added or cut, where its scores stand. Free.

Corporate structure

6 entities across 4 jurisdictions. Read directly from the company’s own 10-K EX-21 filed 2026-02-25 — see the exhibit.

Which other public companies file entities in the same places:

Delaware3 France1 Japan1 Germany1

Subsidiaries of Edwards Lifesciences Corp as disclosed in its SEC filing
Entity	Jurisdiction	Note
Edwards Lifesciences LLC	Delaware
Edwards Lifesciences Holding, Inc.	Delaware
Edwards Lifesciences (U.S.) Inc.	Delaware
Edwards Lifesciences SAS	France
Edwards Lifesciences (Japan) LLC	Japan
Edwards Lifesciences Services GmbH	Germany

Financial health

Two standard screens, computed from the XBRL in FY2025 against FY2024. Every test shows the numbers behind it — a score with its inputs hidden is a number you cannot check.

Piotroski F-score

6 / 9

PASSReturn on assets positiveROA 7.8%
PASSOperating cash flow positiveOCF 1.6B
FAILReturn on assets improving32.0% → 7.8%
PASSCash flow exceeds earningsOCF 1.6B vs NI 1.1B
PASSLong-term debt ratio falling4.6% → 4.4% of assets
FAILCurrent ratio improving4.18 → 3.72
PASSNo share dilution599M → 586M shares
FAILGross margin improving79.5% → 78.0%
PASSAsset turnover improving0.42× → 0.44×

Altman Z-score

11.77safe

Bankruptcy-risk screen combining working capital, retained earnings, operating income, market value against liabilities, and asset turnover. Above 2.99 is the safe zone; below 1.81 is distress.

Six-year record

Year	Revenue	Net income	Free cash flow	Gross margin	Shares
FY2020	$4.4B	—	$647.3M	75.4%	631,900,000
FY2021	$5.2B	$1.5B	$1.4B	76.1%	631,200,000
FY2022	$5.4B	$1.5B	$973.6M	79.9%	624,200,000
FY2023	$6.0B	$1.4B	$642.8M	77.0%	609,400,000
FY2024	$5.4B	$4.2B	$289.9M	79.5%	599,300,000
FY2025

Ownership flow

16 institutions tracked — 8 added, 7 reduced, 1 opened a new position, 1 sold out. Index money added 8,389,515 shares while active managers cut 5,325,953.

Institutional holders of Edwards Lifesciences Corp and their share-count change
Manager	Kind	Shares	Change	Value
FMR LLC	Active fund	8,435,949	−6,067,821	$763.1M
BlackRock, Inc.	Index	58,789,433	+6,060,500	$5.3B
WELLINGTON MANAGEMENT GROUP LLP	Active fund	16,827,967	−5,183,134	$1.5B
CITADEL ADVISORS LLC	Hedge fund	4,271,625

Capital returned

What the company actually paid out and bought back, as reported — the record behind any yield figure.

Shares repurchased

2026Q1: $421.8M
2025Q1: $258.6M
2024Q1: $200,000
2023Q1: $249.3M
2022Q1: $405.6M
2021Q1: $302.6M

Identity

CIK: 0001099800
FIGI: BBG000BRXP69
SIC: 3842 · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Incorporated: DE
Headquarters: IRVINE, CA

Ownership

Institutional: 95.7%
Institutions: 1,924
Insiders: 0.2%

Ownership percentages are a vendor aggregate, not a filing — unlike everything else on this page.

Questions about Edwards Lifesciences Corp

How many subsidiaries does Edwards Lifesciences Corp file with the SEC?: 6, listed in its most recent exhibit 21. They are incorporated across 4 jurisdictions (Delaware, France, Japan, Germany). That exhibit is filed with the company's annual report and is the company's own list, not an estimate.
Is Edwards Lifesciences Corp financially healthy?: Edwards Lifesciences Corp scores 6 out of 9 on the Piotroski F-score. Its Altman Z-score puts it in the safe zone. Every test and the numbers behind it are shown above, so the arithmetic is checkable rather than something you have to take on trust.
Who are the largest institutional holders of Edwards Lifesciences Corp?: Among the managers tracked here, the biggest positions as of the 2026-Q2 13F filings are BlackRock, Inc. (adding), STATE STREET CORP (adding), JPMORGAN CHASE & CO (adding). Direction is the change in share count against that manager's own previous filing; managers with no prior filing are left out rather than counted as new buyers.

This page is one panel of the terminal

The structure map above is the Corporate Blueprint, and in the desktop it is interactive — click any entity to re-centre the map on it and walk the ownership chain. It sits alongside the screener, the scorecard and the filings lab on one desk, on your machine.

Download the terminal See pricing

Sourced from SEC EDGAR primary filings. Figures are as reported by the company and are not investment advice. Scores are standard published screens computed from those filings; every input is shown above so you can check the arithmetic.